The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

48 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
14
Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives.EBI
Cnrs Umr 8532
29
Quantitative structure--activity correlations of rifamycins as inhibitors of viral RNA-directed DNA polymerase and mammalian alpha and beta DNA polymerases.EBI
TBA
49
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.EBI
University of Minnesota
49
6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.EBI
University of Minnesota
32
The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.EBI
Bristol Myers Squibb
9
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?EBI
Instituto De Qu£Mica M£Dica (Iqm, Csic)
2
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,1EBI
TBA
21
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.EBI
University of Minnesota
265
POLYCYCLIC COMPOUND AND APPLICATION THEREOFBDB
Sichuan Huiyu Pharmaceutical
35
N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulatorsBDB
Boehringer Ingelheim International
25
MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORSBDB
Merck Sharp &Amp
9
Immunosuppressant, and preparation method therefor and use thereofBDB
Abbisko Therapeutics Co.
379
P300/CBP hat inhibitorsBDB
Constellation Pharmaceuticals
106
Galactoside inhibitor of galectinsBDB
Galecto Biotech
35
Glycoside derivatives and uses thereofBDB
Novartis
15
Calcium channel inhibitorsBDB
Cavion
63
Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptorsBDB
Neurolixis
107
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseasesBDB
Takeda Pharmaceutical
2
Aldehyde derivative of substitute oxazolidinonesBDB
Wanbury
12
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.BDB
Warsaw University of Technology
2
SF2312 is a natural phosphonate inhibitor of enolase.BDB
University of Texas M. D. Anderson Cancer Center
399
Imidazole amines as modulators of kinase activityBDB
Merck Patent
190
Chemical compounds 542BDB
AstraZeneca
33
Benzimidazole inhibitors of leukotriene productionBDB
Boehringer Ingelheim International
17
Inhibitors of glutaminyl cyclaseBDB
Probiodrug
32
SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORSBDB
Research Triangle Institute
4
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.BDB
Massachusetts General Hospital and Harvard Medical School
93
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityBDB
Theravance
2
Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A.BDB
University of Kentucky
13
(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).BDB
Johnson & Johnson Pharmaceutical Research and Development
17
Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.BDB
National Institutes of Health
3
Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).BDB
Wyeth Research
14
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.BDB
Glaxosmithkline
13
Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.BDB
Vrije Universiteit
11
The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4.BDB
Uppsala University
1
The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.BDB
Smithkline Beecham Pharmaceuticals
9
Neoglycopeptides as inhibitors of oligosaccharyl transferase: insight into negotiating product inhibition.BDB
Massachusetts Institute of Technology
25
Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa.BDB
Bristol Myers Squibb
15
Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.BDB
Instituto De Quimica Medica (Csic)
23
SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.BDB
University of Bologna
6
Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.BDB
Shanghai Institute of Materia Medica